New Animal Drugs; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin
other · Food and Drug Administration · Rule · Published 2012-09-10 · Effective 2012-09-20 · 77 FR 55413
Document
Document number
2012-22196
Federal Register citation
77 FR 55413
CFR reference
21 CFR 510
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2012-09-10
Effective date
2012-09-20
HHS docket
Docket No. FDA-2012-N-0902
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.